Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 10NIH 2NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Gastrointestinal 3Gynecologic 2Thoracic 1Other 1Genitourinary 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 10Myelodysplastic Syndromes 8Leukemia 7Leukemia, Myelomonocytic, Chronic 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 5Anemia, Refractory 5Myeloproliferative Disorders 4Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Anemia 3Thrombocytopenia 2Neutropenia 2Neoplasms 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Juvenile 2Hodgkin Disease 2Congenital Abnormalities 2Anemia, Sickle Cell 2Anemia, Aplastic 2Wilms Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Tourette Syndrome 1Testicular Neoplasms 1Stress Disorders, Post-Traumatic 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Severe Acute Respiratory Syndrome 1Seizures 1

Interventions

Epoetin Alfa 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Fatigue × Classical hematology × Clear all
NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
282 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡